Top

International Urology and Nephrology

Published in:

04-02-2023 | Prostate Cancer | Urology - Original Paper

Association between prostate size and glandular tissue volume of the peripheral zone via novel combined MRI and histopathology: possible pathophysiological implications on prostate cancer development

Authors: Benjamin Lin, Irina Kim Cavdar, Matthew Buxton, Jake Sellers, Luis Brandi, Naseem Helo, Werner T. W. de Riese

Published in: International Urology and Nephrology | Issue 4/2023

Abstract

Purpose

Benign prostatic hyperplasia (BPH) and prostate cancer (PCa) are the two most prevalent urologic diseases affecting elderly men. An inverse relationship between BPH/prostate size and PCa incidence is well documented in the current literature, but the precise mechanism is poorly understood. This study aims to investigate the effect of total prostate volume on total glandular tissue volume of the peripheral zone via a novel combination of magnetic resonance imaging (MRI) and histo-anatomical imaging.

Methods

42 male patients between ages 53–79 years underwent both radical prostatectomy and pre-operative MRI scans. Prostate sizes ranged from 14.8–133.3cc. Quantitative measurements of surgical capsule thickness and glandular epithelial cell density within the peripheral zone (PZ) were obtained on histo-anatomical slides using computer-based imaging software. Quantitative prostatic zonal measurements were obtained from MRI scans. Combining MRI- and histopathology-obtained parameters allowed measurement of the total glandular tissue volume of the PZ (GVPZ). Statistical analysis was performed to identify associations between total prostate volume (TPV) and GVPZ.

Results

The Mann-Whitney U-test showed significant decreases in GVPZ in larger prostates when compared to smaller prostates.

Conclusions

Combined MRI and histopathology techniques provide a novel method for accurate measuring of glandular tissue content within the prostatic PZ. The findings of this pilot study support the hypothesis of PZ compression by an expanding transition zone in large BPH prostates, leading to atrophy of PZ glandular tissue. As the majority of PCa originates in the PZ, this dynamic process may explain the protective effect of large BPH prostates against PCa development.

Sellers J, de Riese WT (2022) Evolving hypothesis that prostate/BPH size matters in protection against prostate cancer. Explor Res Hypothesis Med 7(3):179–183. https://doi.org/10.14218/ERHM.2022.00028CrossRef

Siegel RL, Miller KD, Fuchs HE et al (2022) Cancer statistics. CA Cancer J Clin 72(1):7–33. https://doi.org/10.3322/caac.21708CrossRefPubMed

McVary KT (2006) BPH: epidemiology and comorbidities. Am J Manag Care 12(5 Suppl):S122-128PubMed

Bostwick DG, Cooner WH, Denis L et al (1992) The association of benign prostatic hyperplasia and cancer of the prostate. Cancer 70(1 Suppl):291–301. https://doi.org/10.1002/1097-0142(19920701)70:1+%3c291::aid-cncr2820701317%3e3.0.co;2-4CrossRefPubMed

Liu FC, Hua KC, Lin JR et al (2019) Prostate resected weight and postoperative prostate cancer incidence after transurethral resection of the prostate: a population-based study. Medicine (Baltimore) 98(3):e13897. https://doi.org/10.1097/MD.0000000000013897CrossRefPubMed

Al-Khalil S, Ibilibor C, Cammack JT et al (2016) Association of prostate volume with incidence and aggressiveness of prostate cancer. Res Rep Urol 8:201–205. https://doi.org/10.2147/RRU.S117963CrossRefPubMedPubMedCentral

Buie J, De Riese W, Sharma P (2019) Smaller prostate volume is associated with adverse pathological features and biochemical recurrence after radical prostatectomy. Urol Sci 30(6):255–261. https://doi.org/10.4103/Uros.Uros_28_19CrossRef

Yamashiro JR, de Riese WTW (2021) Any correlation between prostate volume and incidence of prostate cancer: a review of reported data for the last thirty years. Res Rep Urol 13:749–757. https://doi.org/10.2147/RRU.S331506CrossRefPubMedPubMedCentral

Knight AS, Sharma P, de Riese WTW (2022) MRI determined prostate volume and the incidence of prostate cancer on MRI-fusion biopsy: a systemic review of reported data for the last 20 years. Int Urol Nephrol. https://doi.org/10.1007/s11255-022-03351-wCrossRefPubMed

10.

McNeal JE (1968) Regional morphology and pathology of the prostate. Am J Clin Pathol 49(3):347–357. https://doi.org/10.1093/ajcp/49.3.347CrossRefPubMed

11.

Peng Y, Shen D, Liao S et al (2015) MRI-based prostate volume-adjusted prostate-specific antigen in the diagnosis of prostate cancer. J Magn Reson Imaging 42(6):1733–1739. https://doi.org/10.1002/jmri.24944CrossRefPubMedPubMedCentral

12.

Augustin H, Erbersdobler A, Hammerer PG et al (2004) Prostate cancers in the transition zone: part 2; clinical aspects. BJU Int 94(9):1226–1229. https://doi.org/10.1111/j.1464-410X.2004.05147.xCrossRefPubMed

13.

Alcaraz A, Hammerer P, Tubaro A et al (2009) Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review. Eur Urol 55(4):864–873. https://doi.org/10.1016/j.eururo.2008.11.011CrossRefPubMed

14.

Sellers J, Ward E, Weaver P et al (2022) Association of prostate size with capsule thickness and glandular epithelial cell density: the possible clinical implications on prostate cancer development. J Clin Urol. https://doi.org/10.1177/20514158221086399CrossRef

15.

Matsugasumi T, Fujihara A, Ushijima S et al (2017) Morphometric analysis of prostate zonal anatomy using magnetic resonance imaging: impact on age-related changes in patients in Japan and the USA. BJU Int 120(4):497–504. https://doi.org/10.1111/bju.13823CrossRefPubMed

16.

Hricak H, Dooms GC, McNeal JE et al (1987) MR imaging of the prostate gland: normal anatomy. AJR Am J Roentgenol 148(1):51–58. https://doi.org/10.2214/ajr.148.1.51CrossRefPubMed

17.

Freedland SJ, Isaacs WB, Platz EA et al (2005) Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. J Clin Oncol 23(30):7546–7554. https://doi.org/10.1200/JCO.2005.05.525CrossRefPubMed

18.

Thompson IM, Goodman PJ, Tangen CM et al (2003) The influence of finasteride on the development of prostate cancer. N Engl J Med 349(3):215–224. https://doi.org/10.1056/NEJMoă60CrossRefPubMed

19.

Briganti A, Chun FK, Suardi N et al (2007) Prostate volume and adverse prostate cancer features: fact not artifact. Eur J Cancer 43(18):2669–2677. https://doi.org/10.1016/j.ejca.2007.09.022CrossRefPubMed

20.

McNeal J (2003) Central zone histology of the prostate. Hum Pathol 34(3):298. https://doi.org/10.1053/hupa.2003.18CrossRefPubMed

21.

Ayala AG, Ro JY, Babaian R et al (1989) The prostatic capsule: does it exist? Its importance in the staging and treatment of prostatic carcinoma. Am J Surg Pathol 13(1):21–27CrossRefPubMed

22.

Semple JE (1963) Surgical capsule of the benign enlargement of the prostate. Its development and action. Br Med J 1(5346):1640–1643. https://doi.org/10.1136/bmj.1.5346.1640CrossRefPubMedPubMedCentral

23.

Frost JM, Smith LA, Sharma P et al (2019) Possible clinical implications of peripheral zone changes depending on prostate size. Int Urol Nephrol 51(10):1721–1726. https://doi.org/10.1007/s11255-019-02221-2CrossRefPubMed

24.

Sellers J, Wagstaff R, Helo N et al (2022) Association between prostate size and MRI determined quantitative prostate zonal measurements. Res Rep Urol 14:265–274. https://doi.org/10.2147/rru.S362070CrossRefPubMedPubMedCentral

25.

Hoeks CM, Barentsz JO, Hambrock T et al (2011) Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 261(1):46–66. https://doi.org/10.1148/radiol.11091822CrossRefPubMed

26.

Guzman JA, Sharma P, Smith LA et al (2019) Histological changes of the peripheral zone in small and large prostates and possible clinical implications. Res Rep Urol 11:77–81. https://doi.org/10.2147/RRU.S182781CrossRefPubMedPubMedCentral

Title: Association between prostate size and glandular tissue volume of the peripheral zone via novel combined MRI and histopathology: possible pathophysiological implications on prostate cancer development
Authors: Benjamin Lin
Irina Kim Cavdar
Matthew Buxton
Jake Sellers
Luis Brandi
Naseem Helo
Werner T. W. de Riese
Publication date: 04-02-2023
Publisher: Springer Netherlands
Keywords: Prostate Cancer
Magnetic Resonance Imaging
Magnetic Resonance Imaging
Prostate Cancer
Benign Prostatic Hypertrophy
Benign Prostatic Hypertrophy
Published in: International Urology and Nephrology / Issue 4/2023
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-023-03483-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2023

Efficacy and safety of booster vaccination against SARS-CoV-2 in dialysis and renal transplant patients: systematic review and meta-analysis

Efficacy of a novel wearable transcutaneous tibial nerve stimulation device on bladder reflex compared to implantable tibial nerve stimulation in cats

Comparison of estimated glomerular filtration rate equations based on serum creatinine-, cystatin C- and creatinine–cystatin C in elderly Chinese patients

How does Nephroblastomatosis impact the prognosis of unilateral Wilms tumor?

Real-world outcomes of patients with renal cell carcinoma, surgically treated at regional hospitals, based on a prospective long-term survey of the pre-robotic era

COSMC expression as a predictor of remission in IgA nephropathy

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials